Results for gilead sciences

Add to feed Create your own feed

Latest

"Until just now," observed Dr. Tomáš Cihlář, senior scientist at Gilead Sciences, "we could not possibly comprehend that our freedom…could be threatened by something as simple and as banal as a virus."

Citing a lack of evidence that it improves survival, the need for ventilation or time to clinical improvement, the @WHO  has advised doctors against using Gilead Sciences' antiviral Veklury (remdesivir) to treat COVID-19.

Americans are paying the highest price in the world for Remdesivir because the Trump administration is allowing Gilead Sciences to jack up the price on this #COVID19  treatment. This needs to change. We need to lower costs and ensure this treatment is accessible to people.

A WHO panel advised doctors against using Gilead Sciences' antiviral drug remdesivir as a treatment for patients hospitalized with COVID-19.

Gilead Sciences says it was “disappointed the WHO guidelines appear to ignore” evidence with regard to the organization’s recommendation not to use the company’s remdesivir drug as a treatment for Covid-19

Shares of Gilead Sciences Inc. fell in after-hours trading Thursday after a WHO panel recommended against doctors using the drug remdesivir to treat coronavirus patients.

Loading
Loading

Most relevant

The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, according to the drug's maker, Gilead Sciences

Gilead Sciences announced its Covid-19 therapy drug, remdesivir, will cost private insurers $520 for a single vial, hundreds of times its production cost, which researchers have estimated at 93 cents per dose.

JUST IN: The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, the drug’s maker, Gilead Sciences, says

This is a massive scandal Trump's FDA just granted a drug that is being used to treat coronavirus patients, developed previously by Gilead Sciences, "orphan" status, giving the company seven years of exclusivity. by , @fastlerner  @lhfang 

Gilead Sciences announced its Covid-19 therapy drug, remdesivir, will cost private insurers $520 for a single vial, hundreds of times its production cost, which researchers have estimated at 93 cents per dose.

After weeks of donating the antiviral drug remdesivir to hospitals with severely ill coronavirus patients, the drug’s maker, Gilead Sciences, announced that it has settled on a price: $390 per vial, which works out to be roughly $2,340 per treatment course

A study funded by Gilead Sciences evaluating the use of its drug remdesivir to treat 53 seriously ill COVID-19 patients found that some got better. But there was no control group, so strong conclusions weren't possible.

BREAKING: Gilead Sciences says it's aware of positive data emerging from the study of remdesivir for the treatment of COVID-19, and that the trial has met its primary endpoint

BREAKING: The Food and Drug Administration acted after preliminary results from a government-sponsored study showed that Gilead Sciences’ Remdesivir shortened the time to recover by 31 percent for hospitalized COVID-19 patients.

#BREAKING COVID-19: Gilead Sciences reports positive data from trial of antiviral drug #remdesivir 

tweet picture

Loading
Loading